Inside Precision Medicine

  • Home
  • Inside Precision Medicine

Inside Precision Medicine Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Inside Precision Medicine, Media/News Company, .

Exclusive news, features, and analysis on the research, tools, regulations, and applications driving the future of precision medicine with the ultimate goal of transforming patient care and outcomes. Driven by a rapid and exponentially growing market – one that is expected to be valued at more than $126 billion by 2025 – and our commitment to covering the full breadth of the revolutionary field of

precision medicine, Clinical OMICs is now Inside Precision Medicine! Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field. From our core areas of Translational Research, Molecular Diagnostics, Informatics, and Patient Care, to our expanded coverage of Disease Indications and Payer/Regulatory issues, our best-in-class content informs, educates, and enlightens our diverse audience of leading decision-makers.

New Preeclampsia Risk Strategy Guidelines Miss the MarkUSPSTF guidelines for AP in preeclampsia prevention fall short du...
19/07/2025

New Preeclampsia Risk Strategy Guidelines Miss the Mark

USPSTF guidelines for AP in preeclampsia prevention fall short due to weak predictive value of moderate-risk factors.

USPSTF guidelines for AP in preeclampsia prevention fall short due to weak predictive value of moderate-risk factors.

AI Turns ECGs into Powerful Heart Disease Screening Tool #AI model outperforms cardiologists in detecting hidden structu...
18/07/2025

AI Turns ECGs into Powerful Heart Disease Screening Tool #

AI model outperforms cardiologists in detecting hidden structural heart disease from routine ECGs, advancing early screening.

AI model outperforms cardiologists in detecting hidden structural heart disease from routine ECGs, advancing early screening.

New DMD Therapy Inhibits Glutamate Dehydrogenase 1Inhibiting the enzyme glutamate dehydrogenase 1 (GLUD1) can restore mu...
18/07/2025

New DMD Therapy Inhibits Glutamate Dehydrogenase 1

Inhibiting the enzyme glutamate dehydrogenase 1 (GLUD1) can restore muscle function in patients with Duchenne muscular dystrophy.

VIB KU Leuven Center for Brain & Disease Research

Inhibiting the enzyme glutamate dehydrogenase 1 (GLUD1) can restore muscle function in patients with Duchenne muscular dystrophy.

Robotic “Copilot” Autonomously Assists with SurgeryAn open-source, artificial intelligence simulator can train surgical ...
18/07/2025

Robotic “Copilot” Autonomously Assists with Surgery

An open-source, artificial intelligence simulator can train surgical robots to autonomously perform multi-stage tasks during laparoscopic operations.

Chinese University

An open-source, artificial intelligence simulator can train surgical robots to autonomously perform multi-stage tasks during laparoscopic operations.

DON'T MISS OUT! A Conversation with Eric Topol, MD, and Editor in Chief Damian DohertyBroadcast Date: Wednesday, July 2...
18/07/2025

DON'T MISS OUT! A Conversation with Eric Topol, MD, and Editor in Chief Damian Doherty

Broadcast Date: Wednesday, July 23, 2025
Time: 9:00 am PT, 12:00 pm ET, 18:00 CEST

On July 23, join Inside Precision Medicine for another compelling installment of IPM Live, the interview series that brings you face-to-face with the leading experts driving the most important advances in precision medicine today. Register now to join us for this free IPM Live: https://hubs.li/Q03wxKlR0

This conversation is uniquely focused on the cutting-edge science and evidence-based strategies behind extending healthspan.

Engineered Microbiome Therapy Improves Gut Colonization in Clinical TrialsClinical data shows promise for a novel approa...
18/07/2025

Engineered Microbiome Therapy Improves Gut Colonization in Clinical Trials

Clinical data shows promise for a novel approach to achieve stable gut colonization with a microbiome therapy for kidney stones.

Stanford University

Clinical data shows promise for a novel approach to achieve stable gut colonization with a microbiome therapy for kidney stones.

Aggressive Ovarian Cancer Therapy Resistance Tied to Whole-Genome DoublingWGD leads to chromosomal instability, increase...
18/07/2025

Aggressive Ovarian Cancer Therapy Resistance Tied to Whole-Genome Doubling

WGD leads to chromosomal instability, increased metastatic potential, drug resistance, and poorer clinical outcomes.

Memorial Sloan Kettering Cancer Center

WGD leads to chromosomal instability, increased metastatic potential, drug resistance, and poorer clinical outcomes.

Aluminum in Vaccines Not Linked to Autism or Chronic DiseasesLargest-ever study of 1.2 million children finds no link be...
17/07/2025

Aluminum in Vaccines Not Linked to Autism or Chronic Diseases

Largest-ever study of 1.2 million children finds no link between aluminum in vaccines and chronic conditions, including autism.

Statens Serum Institut - SSI

Largest-ever study of 1.2 million children finds no link between aluminum in vaccines and chronic conditions, including autism.

Innate Immunity Gene Linked with Organ Rejection RiskKidney transplant recipients with a donor who has a different versi...
17/07/2025

Innate Immunity Gene Linked with Organ Rejection Risk

Kidney transplant recipients with a donor who has a different version of an innate immunity gene are at increased risk of premature fibrosis and organ rejection, researchers reported.

University of Pittsburgh School of Medicine Graduate Studies

Kidney transplant recipients with a donor who has a different version of an innate immunity gene are at increased risk of premature fibrosis and organ rejection, researchers reported.

Take II: Off-the-Shelf CAR T Shines in Relapsed/Refractory Lymphoma PatientsThe allogeneic Azer-cel showed impressive re...
17/07/2025

Take II: Off-the-Shelf CAR T Shines in Relapsed/Refractory Lymphoma Patients

The allogeneic Azer-cel showed impressive response rates in a Phase Ib study with DLBCL patients who had failed autologous CAR T cell therapy treatments.


The allogeneic Azer-cel showed impressive response rates in a Phase Ib study with DLBCL patients who had failed autologous CAR T cell therapy treatments.

AI-Guided Patient Stratification Uncovers New Hope for Failed Alzheimer’s DrugA novel AI tool has retroactively shown th...
17/07/2025

AI-Guided Patient Stratification Uncovers New Hope for Failed Alzheimer’s Drug

A novel AI tool has retroactively shown that Alzheimer's patients with slow disease progression can benefit from a failed experimental drug.

University of Cambridge

A novel AI tool has retroactively shown that Alzheimer's patients with slow disease progression can benefit from a failed experimental drug.

🎧 More than a Feeling: Predicting Biology with Spatiotemporal MultiomicsMike Previte, PhD, Element Biosciences' CTO and ...
17/07/2025

🎧 More than a Feeling: Predicting Biology with Spatiotemporal Multiomics

Mike Previte, PhD, Element Biosciences' CTO and co-founder, is reimagining how we study cells and model disease to evolve precision medicine. Don't miss IPM's lates episode of the Behind the Breakthroughs podcast.

Mike Previte, PhD, Element Biosciences CTO and co-founder, is reimagining how we study cells and model disease to evolve precision medicine.

Address


Website

Alerts

Be the first to know and let us send you an email when Inside Precision Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share

About the Publication

Clinical OMICs is the leading source of practical insights for pathologists, clinicians, researchers, and scientists working to translate important findings across the broad range of “omics” technologies to deliver on the promise of molecular and precision medicine for patients.

Through a combination of industry news, features, and thoughtful analyses, Clinical OMICs emphasizes the practical—relevant knowledge and available tools—and empowers healthcare professionals to harness the application of molecular-based technologies and transform patient care. From sequencers and biomarkers to software and clinical decision support and everything in between, Clinical OMICs helps its readers stay current on the most critical research, tools, regulations, and applications affecting the practice of molecular pathology, the development of omics technologies and diagnostics, and the delivery of precision medicine.

Clinical OMICs provides readers with up-to-date content through its bimonthly Magazine, eNewsletters, and daily articles available on ClinicalOMICs.com.